Treatment of a malignant enterocutaneous fistula with octreotide acetate.
An enterocutaneous malignant fistula developed in a patient who had a retroperitoneal angiosarcoma. He was treated with octreotide acetate subcutaneously. Drainage decreased and ceased after 2 weeks of therapy. The closure of this malignant fistula suggests that palliative therapy with octreotide acetate merits further study in view of the grave prognosis of this complication.
Ayache
S
S
Department of Veterans Affairs Medical Center, Washington, DC, USA.
Wadleigh
R G
RG
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017577:Cutaneous Fistula; D017809:Fatal Outcome; D006394:Hemangiosarcoma / Q000188:drug therapy*; D006801:Humans; D007412:Intestinal Fistula; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy*
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide